13F HOLDINGS REPORT
Integral Health Asset Management, LLC
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0001172661-24-003360
Total Value
$1.05B
Positions
72
Other Managers
0
Confidential Omitted
No
Holdings (72)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | INSMED INC | INSM | 1,550,000 | $103.8M | 9.87% |
| 2 | TENET HEALTHCARE CORP | THC | 500,000 | $66.5M | 6.32% |
| 3 | CYTOKINETICS INC | CYTK | 1,000,000 | $54.2M | 5.15% |
| 4 | BOSTON SCIENTIFIC CORP | BSX | 650,000 | $50.1M | 4.76% |
| 5 | ELEVANCE HEALTH INC | ELV | 80,000 | $43.3M | 4.12% |
| 6 | BLUEPRINT MEDICINES CORP | 09627Y109 | 340,000 | $36.6M | 3.48% |
| 7 | NOVARTIS AG | NVSEF | 300,000 | $31.9M | 3.03% |
| 8 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 1,100,000 | $29.7M | 2.82% |
| 9 | MERCK & CO INC | MRK | 235,000 | $29.1M | 2.76% |
| 10 | HUMANA INC | HUM | 75,000 | $28.0M | 2.66% |
| 11 | ENCOMPASS HEALTH CORP | EHC | 300,000 | $25.7M | 2.44% |
| 12 | UNIVERSAL HLTH SVCS INC | 913903100 | 130,000 | $24.0M | 2.28% |
| 13 | IONIS PHARMACEUTICALS INC | IONS | 500,000 | $23.8M | 2.26% |
| 14 | INARI MED INC | 45332Y109 | 400,000 | $19.3M | 1.83% |
| 15 | VERA THERAPEUTICS INC | VERA | 500,000 | $18.1M | 1.72% |
| 16 | CRINETICS PHARMACEUTICALS IN | CRNX | 400,000 | $17.9M | 1.70% |
| 17 | BECTON DICKINSON & CO | BDX | 75,000 | $17.5M | 1.67% |
| 18 | THE CIGNA GROUP | 125523100 | 50,000 | $16.5M | 1.57% |
| 19 | TARSUS PHARMACEUTICALS INC | TARS | 590,000 | $16.0M | 1.52% |
| 20 | KRYSTAL BIOTECH INC | KRYS | 85,000 | $15.6M | 1.48% |
| 21 | ARCELLX INC | ACLX | 275,000 | $15.2M | 1.44% |
| 22 | ICON PLC | ICLR | 45,000 | $14.1M | 1.34% |
| 23 | EDWARDS LIFESCIENCES CORP | EW | 150,000 | $13.9M | 1.32% |
| 24 | THERMO FISHER SCIENTIFIC INC | TMO | 25,000 | $13.8M | 1.31% |
| 25 | QUEST DIAGNOSTICS INC | DGX | 100,000 | $13.7M | 1.30% |
| 26 | VIKING THERAPEUTICS INC | VKTX | 250,000 | $13.3M | 1.26% |
| 27 | VIKING THERAPEUTICS INC | VKTX | 250,000 | $13.3M | 1.26% |
| 28 | REVOLUTION MEDICINES INC | RVMDW | 325,000 | $12.6M | 1.20% |
| 29 | AMGEN INC | AMGN | 40,000 | $12.5M | 1.19% |
| 30 | IONIS PHARMACEUTICALS INC | IONS | 250,000 | $11.9M | 1.13% |
| 31 | MCKESSON CORP | MCK | 20,000 | $11.7M | 1.11% |
| 32 | REGENXBIO INC | RGNX | 950,000 | $11.1M | 1.06% |
| 33 | TARSUS PHARMACEUTICALS INC | TARS | 400,000 | $10.9M | 1.03% |
| 34 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 145,000 | $9.9M | 0.94% |
| 35 | SANOFI | SNYNF | 200,000 | $9.7M | 0.92% |
| 36 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 220,000 | $9.7M | 0.92% |
| 37 | NEUROCRINE BIOSCIENCES INC | NBIX | 70,000 | $9.6M | 0.92% |
| 38 | TELEFLEX INCORPORATED | TFX | 45,000 | $9.5M | 0.90% |
| 39 | ELI LILLY & CO | LLY | 10,000 | $9.1M | 0.86% |
| 40 | GLOBUS MED INC | GMED | 125,000 | $8.6M | 0.81% |
| 41 | BRUKER CORP | BRKRP | 130,000 | $8.3M | 0.79% |
| 42 | CRISPR THERAPEUTICS AG | CRSP | 150,000 | $8.1M | 0.77% |
| 43 | OSCAR HEALTH INC | OSCR | 500,000 | $7.9M | 0.75% |
| 44 | REPLIGEN CORP | RGEN | 60,000 | $7.6M | 0.72% |
| 45 | DENALI THERAPEUTICS INC | DNLI | 325,000 | $7.5M | 0.72% |
| 46 | TENAYA THERAPEUTICS INC | TNYA | 2,325,000 | $7.2M | 0.68% |
| 47 | SANA BIOTECHNOLOGY INC | SANA | 1,200,000 | $6.6M | 0.62% |
| 48 | ELANCO ANIMAL HEALTH INC | ELAN | 450,000 | $6.5M | 0.62% |
| 49 | MEREO BIOPHARMA GROUP PLC | MREO | 1,775,000 | $6.4M | 0.61% |
| 50 | MERUS N V | N5749R100 | 100,000 | $5.9M | 0.56% |
| 51 | INSULET CORP | PODD | 25,000 | $5.0M | 0.48% |
| 52 | QUIDELORTHO CORP | QDEL | 150,000 | $5.0M | 0.47% |
| 53 | RELAY THERAPEUTICS INC | RLAY | 750,000 | $4.9M | 0.46% |
| 54 | SURGERY PARTNERS INC | SGRY | 200,000 | $4.8M | 0.45% |
| 55 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 100,000 | $4.5M | 0.43% |
| 56 | INTUITIVE SURGICAL INC | ISRG | 10,000 | $4.4M | 0.42% |
| 57 | CATALYST PHARMACEUTICALS INC | CPRX | 275,000 | $4.3M | 0.40% |
| 58 | ROIVANT SCIENCES LTD | ROIV | 400,000 | $4.2M | 0.40% |
| 59 | KEROS THERAPEUTICS INC | KROS | 85,000 | $3.9M | 0.37% |
| 60 | HOLOGIC INC | HOLX | 50,000 | $3.7M | 0.35% |
| 61 | 89BIO INC | 282559103 | 450,000 | $3.6M | 0.34% |
| 62 | DYNE THERAPEUTICS INC | DYN | 100,000 | $3.5M | 0.34% |
| 63 | SCHOLAR ROCK HLDG CORP | SRRK | 400,000 | $3.3M | 0.32% |
| 64 | CABALETTA BIO INC | CABA | 425,000 | $3.2M | 0.30% |
| 65 | EDITAS MEDICINE INC | EDIT | 675,000 | $3.2M | 0.30% |
| 66 | APOGEE THERAPEUTICS INC | APGE | 80,000 | $3.1M | 0.30% |
| 67 | NURIX THERAPEUTICS INC | NRIX | 150,000 | $3.1M | 0.30% |
| 68 | FATE THERAPEUTICS INC | FATE | 850,000 | $2.8M | 0.26% |
| 69 | NEUROGENE INC | NGNE | 70,000 | $2.5M | 0.24% |
| 70 | SPYRE THERAPEUTICS INC | SYRE | 100,000 | $2.4M | 0.22% |
| 71 | KURA ONCOLOGY INC | KURA | 100,000 | $2.1M | 0.20% |
| 72 | REVANCE THERAPEUTICS INC | 761330109 | 500,000 | $1.3M | 0.12% |